Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Biosafety Virtual Library Resources
(VLR)
published: 02 Sep 2007
last updated: 02 May 2012
Risk Assessment and Management of Genetically Modified Organisms under Australia's Gene Technology Act: Considerations for Regulatory Development
EN
Organization:Research and Information System for Developing Countries ()Phone:Fax:Email:Website:
2006
EN
Asian Biotechnology and Development Review Vol. 8 No. 3, pp 1-16;
EN
¸ 2006, RIS. All rights reserved
EN
This paper examines some of the potential regulatory issues that may be affecting the slow review process and approval of transgenic technologies in Australia as follows: *A brief introduction to the regulatory structure in Australia is provided *The impacts of regional, national and state jurisdictions are considered *Cost-benefits analysis in decision making is discussed *The use of probabilistic risk assessments, based on mathematical models, in certain circumstances are discussed *Potential problems inherent in majority voting in a committee (i.e. group decision-making) are examined with recommendations
EN
- GBF-T17. Strengthen biosafety and distribute benefits of biotechnology
No
No
No
Identifier (ISBN, ISSN, etc.)
Format
Adobe Acrobat Reader (16 pages)
PDF
Keywords and any other relevant information
LMO categories: All LMO categories
